Table 35Summary of embolization treatment tumor characteristics: RCTs

Study
Rating
Group
N
Bilobar %Number of LesionsLesion Size Range (cm)Other Lesion Characteristics
Malagari et al. 201061
Poor
DEB
41
NR1: 29.2%, >1: 26.8%,Sum of tumor diameters, mean (SD): 8.35 (2.75)Multinodular: 43.9%
TAE
43
NR1: 34.9%, >1: 32.6%;Sum of tumor diameters, mean (SD): 8.1 (2.8)Multinodular: 32.6%
Sacco et al. 201162
Fair
TACE
34
17.6Mean:1.5
Range: 1–3
Range: 1.3–8.8NR
DEB
33
24.2Mean:1.3Range: 1.0–13.0NR

Abbreviations: DEB = drug-eluting bead; N = number; NR = not reported; SD = standard deviation; TACE = transarterial chemoembolization; TAE = transarterial embolization.

From: Results

Cover of Local Therapies for Unresectable Primary Hepatocellular Carcinoma
Local Therapies for Unresectable Primary Hepatocellular Carcinoma [Internet].
Comparative Effectiveness Reviews, No. 114.
Belinson S, Yang Y, Chopra R, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.